Perioperative medicine & outcomes

Associations of inflammatory biomarkers with morbidity and mortality after noncardiac surgery: A systematic review and meta-analysis

J Clin AnesthPublished Systematic review and meta-analysis

Pooled result · All-cause mortality, elevated preoperative CRPResult — go to the resultOdds ratio 1.57 95% CI 1.29–1.90

Authors' conclusion

Inflammatory biomarker levels in the perioperative period were associated with all-cause mortality and adverse cardiovascular events in patients undergoing noncardiac surgery.

Study context

Population
Noncardiac surgery patients with inflammatory biomarkers measured preoperatively and/or within 10 days after surgery
Participants
121,849 patients · 52 studies
Comparison
Elevated vs lower perioperative inflammatory biomarker levels
Outcome
All-cause mortality and major adverse cardiovascular events
Methodological detailsrandom-effects (DerSimonian-Laird), multivariable adjusted associations, duplicate data extraction, MEDLINE, EMBASE, and CENTRAL searched from inception until May 2023
  • Random-effects (DerSimonian-Laird)
  • Multivariable adjusted associations
  • Duplicate data extraction
  • MEDLINE, EMBASE, and CENTRAL searched from inception until May 2023

Pooled result

All-cause mortality, elevated preoperative CRP

Odds ratio

1.57

95% CI 1.29–1.90

Elevated vs lower perioperative inflammatory biomarker levels
OR 1.57 (95% CI 1.29–1.90)

As reported in the abstract

Further pooled results

All-cause mortality by surgery population, elevated preoperative C-reactive protein (CRP) (subgroup)

OR (95% CI)
Non-cancer surgery populationsI2 = 0%, 4 studies2.10 (1.92–2.31)
Cancer surgery populationsI2 = 83%, 24 studies1.51 (1.26–1.81)

All-cause mortality, higher postoperative CRP

OR (95% CI)
Higher postoperative CRP levelsI2 = 90%, 7 studies1.61 (1.17–2.20)

Major cardiovascular events, higher preoperative CRP

OR (95% CI)
Higher preoperative CRP levelsI2 = 0%, 2 studies2.11 (1.51–2.94)

All-cause mortality, other preoperative biomarkers

OR (95% CI)
FibrinogenI2 = 52%, 5 studies1.48 (1.05–2.09)
interleukin-6I2 = 27%, 3 studies1.17 (1.07–1.28)
Tumour necrosis factor-alphaI2 = 0%, 2 studies1.37 (1.16–1.61)
  • All-cause mortality by surgery population, elevated preoperative CRP (subgroup): p for subgroup difference = 0.001

All-cause mortality by surgery population, elevated preoperative CRP (subgroup)

Association stronger in non-cancer than cancer surgery populations

Original publication

Associations of inflammatory biomarkers with morbidity and mortality after noncardiac surgery: A systematic review and meta-analysis. J Clin Anesth. Published 2 July 2024. doi:10.1016/j.jclinane.2024.111540

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.